Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The market is witnessing high growth due to factors such as increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure.

[343 Pages Report] The anatomic pathology market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%.

Download PDF Brochure: @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145

Anatomic Pathology Market by Region

This anatomic pathology Market Research report aims to provide insights into the global market. It provides valuable information on anatomic pathology product service and application. Details on regional Anatomical pathology markets for these segments are also presented in this report. In addition, leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Market report provides a detailed overview of the major drivers, restraints, challenges, opportunities, trends and strategies impacting the anatomic pathology market, along with revenue estimates forecasts and market share analysis.

The global anatomic pathology market is segmented on the basis of product service and application. Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The anatomic pathology market is witnessing high growth due to factors such as increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure.

Get Sample Copy for more Professional and Technical insights @ https://www.marketsandmarkets.com/Market-Reports/anatomic-pathology...

Anatomic Pathology Services segment accounted for the largest share of the global anatomic pathology market in 2020.

Based on product service, the anatomic pathology market is segmented into services, consumables, and instruments. The services segment accounted for the largest market share in 2020. The large share of this segment can be attributed to the availability of reimbursements for diagnostic tests, rapid growth in the geriatric population, and the increasing incidence of cancer and other chronic diseases.

By Application, disease diagnostics accounted for the largest market share in 2020

Based on application, the anatomic pathology market is segmented into disease diagnostics and medical research. The disease diagnostics segment accounted for a larger share of the market in 2020 due to the rapid growth in the geriatric population and the increasing incidence of cancer and other chronic diseases.

By End User, Hospital laboratories accounted for the largest market share in 2020

Based on end user, the anatomic pathology market is segmented into hospital laboratories, clinical laboratories, and other end users. Hospital laboratories accounted for the largest share in 2020. The large share of this segment can be attributed to the increasing number of patient visits to hospitals, the growing number of in-house diagnostic procedures performed in hospitals, growing awareness regarding early disease diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.

North America dominates the anatomic pathology market

The global anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW). In 2020, North America accounted for the largest share of the anatomic pathology market. Factors such as the rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the anatomic pathology market in North America.

The major players in the anatomic pathology market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), and PHC Holdings Corporation (Japan).

Make an Enquire to Buy this Report @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1...

Recent Developments

Sakura Finetek Launched four new ready-to-use antibodies for the Tissue-Tek Genie Advanced Staining System
Sakura Finetek launched the Accu-Cut SRM 300 LT Manual Microtome.
Hoffmann-La Roche received the CE approval for its BenchMark ULTRA Plus Staining System.
BD received FDA approval for its new automated cervical cancer screening systems, BD Totalys MultiProcessor and BD Totalys SlidePrep instruments
Frequently Asked Questions (FAQ):

What is the projected market value of the global anatomic pathology market?
What is the estimated growth rate (CAGR) of the global anatomic pathology market for the next five years?
Who are the major players offering anatomic pathology in the market?
Which end user segment of the global anatomic pathology market is expected to witness the highest growth?
Which product and service segment is expected to have the largest market share during the forecast period?